Robert Charles Breedlove - 14 Jul 2026 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Reporting relationship: Principal Accounting Officer
Issuer ticker: PHAT
Reported as of: 14 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2026, 16:30:48 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Charles Breedlove

Key filing fact

Robert Charles Breedlove filed Form 4 for Phathom Pharmaceuticals, Inc. (PHAT) on 16 Jul 2026.

Key facts

This page summarizes Robert Charles Breedlove's Form 4 filing for Phathom Pharmaceuticals, Inc. (PHAT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jul 2026, 16:30.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066645 Primary reporting owner

Breedlove Robert Charles

Relationship: Principal Accounting Officer
Address: C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK
Signature: /s/ Robert Charles Breedlove
Signature date: 16 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHAT transaction

Common Stock

Tax liability

Transaction value
Shares: -1,555
Change %: -2.5%
Price: $11.04^*
Shares after: 59,925
Date: 14 Jul 2026
Ownership: Direct
Footnotes: F1

PHAT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,945
Date: 14 Jul 2026
Ownership: By 401(k)

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.